INTERNATIONAL PATENT: AMGEN INC. FILES APPLICATION FOR "DOSING REGIMEN FOR ANTI-DLL3 AGENT"

GENEVA, April 14 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2025/048619) for "DOSING REGIMEN FOR ANTI-DLL3 AGENT" on Sep 30, 2025. With publication no. WO/2026/075950, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERSON, Erik (c/o Amgen Inc., One Amgen Center DriveLaw Dept-Patent Operations, Mail Stop 28-5-AThousand Oaks, California 91320-1799), MINOCHA, Mukul (c/o Amgen Inc., One Amgen Center DriveLaw Dept-Patent Operations, Mail Stop 28-5-AThousand O...